S
Sunil Shaunak
Researcher at Imperial College London
Publications - 65
Citations - 3077
Sunil Shaunak is an academic researcher from Imperial College London. The author has contributed to research in topics: Viral replication & Virus. The author has an hindex of 24, co-authored 65 publications receiving 2973 citations. Previous affiliations of Sunil Shaunak include Hammersmith Hospital & University of Connecticut.
Papers
More filters
Journal ArticleDOI
Clustered Mutations in HIV-1 Gag Are Consistently Required for Escape from Hla-B27–Restricted Cytotoxic T Lymphocyte Responses
Anthony D. Kelleher,Chad Long,Edward C. Holmes,Rachel L. Allen,Jamie R F Wilson,Christopher P. Conlon,Cassy Workman,Sunil Shaunak,Kara Olson,Philip J. R. Goulder,Philip J. R. Goulder,Christian Brander,Graham S. Ogg,John S. Sullivan,Wayne B. Dyer,Ian M. Jones,Andrew J. McMichael,Sarah Rowland-Jones,Rodney E. Phillips +18 more
TL;DR: Phylogenetic analyses indicated that substitutions emerged under natural selection rather than by genetic drift or linkage for outgrowth of CTL escape viruses required high viral loads and additional, possibly compensatory, mutations in the gag protein.
Journal ArticleDOI
Persistence of episomal HIV-1 infection intermediates in patients on highly active anti-retroviral therapy.
Mark Sharkey,Ian Teo,Thomas C. Greenough,Natalia Sharova,Katherine Luzuriaga,John L. Sullivan,R. Pat Bucy,Leondios G. Kostrikis,Ashley T. Haase,Claire Veryard,Raul Davaro,Sarah H. Cheeseman,Jennifer S. Daly,Carol A. Bova,Richard T. Ellison,Brian J. Mady,Kwan Kew Lai,Graeme Moyle,Mark T. Nelson,Brian Gazzard,Sunil Shaunak,Mario Stevenson +21 more
TL;DR: It is demonstrated here ongoing virus replication in a large percentage of infected individuals on highly active anti-retroviral therapy, despite sustained undetectable levels of plasma viral RNA, has important implications for the clinical management of HIV-1-infected individuals and for the development of virus eradication strategies.
Journal ArticleDOI
Polyvalent dendrimer glucosamine conjugates prevent scar tissue formation
Sunil Shaunak,Sharyn Thomas,Elisabetta Gianasi,Antony Godwin,Emma Jones,Ian Teo,Kamiar Mireskandari,Philip J. Luthert,Ruth Duncan,Steve Patterson,Peng T. Khaw,Steve Brocchini +11 more
TL;DR: It is concluded that synthetically engineered macromolecules such as the dendrimers described here can be tailored to have defined immuno-modulatory and antiangiogenic properties, and they can be used synergistically to prevent scar tissue formation.
Journal ArticleDOI
Site-specific PEGylation of native disulfide bonds in therapeutic proteins
Sunil Shaunak,Antony Godwin,Ji-Won Choi,Sibu Balan,Elisa Pedone,Damotharan Vijayarangam,Sibylle Heidelberger,Ian Teo,Mire Zloh,Steve Brocchini +9 more
TL;DR: It is shown that native disulfides in human interferon α-2b and in a fragment of an antibody to CD4+ can be modified by site-specific bisalkylation of the two cysteine sulfur atoms to form a three-carbon PEGylated bridge.
Journal ArticleDOI
Site-Specific PEGylation of Protein Disulfide Bonds Using a Three-Carbon Bridge
Sibu Balan,Ji-Won Choi,Antony Godwin,Ian Teo,Carlos M. Laborde,Sibylle Heidelberger,Mire Zloh,Sunil Shaunak,Steve Brocchini +8 more
TL;DR: The studies suggest that peptides, proteins, enzymes, and antibody fragments can be site-specifically PEGylated across a native disulfide bond using three-carbon bridges without destroying their tertiary structure or abolishing their biological activity.